145 related articles for article (PubMed ID: 30723271)
21. Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy.
Motomura T; Ono Y; Shirabe K; Fukuhara T; Konishi H; Mano Y; Toshima T; Yoshiya S; Muto J; Ikegami T; Yoshizumi T; Maehara Y
HPB Surg; 2012; 2012():185496. PubMed ID: 23132957
[TBL] [Abstract][Full Text] [Related]
22. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K
PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449
[TBL] [Abstract][Full Text] [Related]
23. New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.
Jee MH; Hong KY; Park JH; Lee JS; Kim HS; Lee SH; Jang SK
J Virol; 2015 Dec; 90(6):3044-55. PubMed ID: 26719248
[TBL] [Abstract][Full Text] [Related]
24. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
25. Host genetic variants influencing the clinical course of hepatitis C virus infection.
Matsuura K; Tanaka Y
J Med Virol; 2016 Feb; 88(2):185-95. PubMed ID: 26211651
[TBL] [Abstract][Full Text] [Related]
26. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
[TBL] [Abstract][Full Text] [Related]
27. [Role of transforming growth factor-beta in the development of some liver diseases].
Raikhelson KL; Karev VE; Marchenko NV; Semenov NV; Palgova LK; Baranovsky AY
Ter Arkh; 2014; 86(2):44-8. PubMed ID: 24772507
[TBL] [Abstract][Full Text] [Related]
28. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
Ali MA; Koura BA; el-Mashad N; Zaghloul MH
Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
El Bassuoni MA; Talaat RM; Ibrahim AA; Shaker OT
Egypt J Immunol; 2008; 15(1):39-50. PubMed ID: 20306668
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.
Wang H; Mengsteab S; Tag CG; Gao CF; Hellerbrand C; Lammert F; Gressner AM; Weiskirchen R
World J Gastroenterol; 2005 Apr; 11(13):1929-36. PubMed ID: 15800982
[TBL] [Abstract][Full Text] [Related]
31. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
33. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
34. The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients.
Abu El Makarem MA; El-Sagheer GM; Abu El-Ella MA
Med Princ Pract; 2018; 27(2):115-121. PubMed ID: 29402841
[TBL] [Abstract][Full Text] [Related]
35. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
36. Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.
Amiot L; Vu N; Rauch M; L'Helgoualc'h A; Chalmel F; Gascan H; Turlin B; Guyader D; Samson M
J Hepatol; 2014 Feb; 60(2):245-52. PubMed ID: 24036009
[TBL] [Abstract][Full Text] [Related]
37. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
38. Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C.
Miyoshi K; Ikebuchi Y; Ishida C; Okamoto K; Murawaki Y
Intern Med; 2014; 53(14):1461-8. PubMed ID: 25030555
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection.
Tag CG; Mengsteab S; Hellerbrand C; Lammert F; Gressner AM; Weiskirchen R
Cytokine; 2003 Dec; 24(5):173-81. PubMed ID: 14596813
[TBL] [Abstract][Full Text] [Related]
40. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
